February 2, 2018—A team of independent health policy experts have questioned the major findings in a recent New England Journal of Medicine (NEJM) study critical of the 340B drug pricing program. In its Jan. 24 issue, the journal published a study authored by Sunita Desai, Ph.D., and J. Michael McWilliams, M.D., Ph.D., that raised questions about whether 340B hospitals are … [Read more...]
Bipartisan Senate Group Asks Leaders to Help Block 340B Hospital Cuts
December 6, 2017—Efforts to block impending cuts to Medicare Part B payments to 340B hospitals gained momentum this week as a bipartisan group of six U.S. senators urged party leaders to enact legislation stopping the cuts before the end of December. The Dec. 5 letter from Sens. John Thune (R-S.D.), Rob Portman (R-Ohio), Shelley Moore Capito (R-W.Va.), Bill Nelson (D-Fla.), … [Read more...]
Senate Hearing Next Week on Outrageous Prescription Drug Prices
December 5, 2017—The Senate Health, Education, Labor and Pensions (HELP) Committee is holding a Dec. 12 hearing on new National Academies of Sciences (NAS) findings on why medicines cost so much and recommendations on how to fix the problem. The NAS’s Nov. 30 report is drawing attention for calling on the federal government to negotiate drugs prices with manufacturers, deny … [Read more...]
340B Hospital Leaders Urge Congress to Block Devastating Medicare Cuts
November 29, 2017—Hospital leaders from 23 states are on Capitol Hill today to urge passage of a bipartisan bill to stop deep reductions in Medicare Part B drug payments to hospitals that participate in the 340B drug discount program. Across the country, meanwhile, 340B hospitals are contacting their lawmakers via email and social media to convey their deep concerns about the … [Read more...]
Judge Orders Dec. 21 Hearing in Suit to Block Huge Cuts to 340B Hospitals
November 28, 2017—A federal district judge has scheduled a Dec. 21 hearing in the lawsuit seeking to stop drastic Medicare Part B drug reimbursement cuts for many 340B hospitals from taking effect on Jan. 1. … [Read more...]
CMS Finalizes Nearly 30 Percent Cut in Medicare Part B Drug Payments to 340B Hospitals
November 1, 2017—The Centers for Medicare & Medicaid Services late today published a final Outpatient Prospective Payment System (OPPS) regulation that cuts Medicare Part B drug reimbursement to hospitals in the 340B drug discount program for separately payable drugs by nearly 30 percent, from average sales price (ASP) plus 6 percent to ASP minus 22.5 percent. The reduction … [Read more...]
House E&C Oversight Subcommittee 340B Hearing Recap
October 11, 2017—The House Energy & Commerce oversight subcommittee held its second hearing on the 340B program this morning, focusing on how covered entities track and use their savings to improve patient care. Three 340B hospitals and health systems testified – Mission Health (N.C.), The Johns Hopkins Hospital (Md.), and Northside Hospital (Ga.). The committee also heard … [Read more...]